HLB Co., Ltd. (KOSDAQ:028300)

Market Cap	6.58T -6.3%
Revenue (ttm)	84.17B +23.6%
Net Income	-220.50B
EPS	-1,680.07
Shares Out	132.90M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	643,228
Average Volume	608,308
Open	48,550
Previous Close	49,500
Day's Range	46,600 - 49,100
52-Week Range	36,150 - 69,200
Beta	n/a
RSI	27.73
Earnings Date	Mar 27, 2026

About HLB Co., Ltd.

HLB Co., Ltd. manufactures pharmaceutical products, and builds ships. It manufactures and sells various types of lifeboats for marine plants, drill ships, and cruise vessels in South Korea. The company offers conventional type lifeboats, free fall type lifeboats, and rescue boats. It also provides marine and yacht engines; hooks; RIB, patrol, fishing, aluminum, and leisure boats; fishery inspection ships; and safety goods, as well as lifeboat and davit inspection and repair services, service engineering training, and spare parts for lifeboats a...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1975
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 028300

Financial Performance

In 2025, HLB Co., Ltd.'s revenue was 84.17 billion, an increase of 23.55% compared to the previous year's 68.13 billion. Losses were -220.50 billion, 139.7% more than in 2024.